Search

Irach B Taraporewala

from White Plains, NY
Age ~68
Get Report
Also known as:
Irach B Taraporewal, H A, Irach A
Phone and address:
24 Carhart Ave, White Plains, NY 10605
(914) 422-0227
Related to:
Claudia C Garcia, 24
Connected to:
Junaid Tarar, 38Nadeem Tarar, 60Rishi Tarar, 48Salman M Tarar, 28Sana Z Tarar, 38Mirela D Tararache, 47Alla A Taras, 63Yelena Taras, 54Gianni Taraschi, 51June Taraschuk, 72

Irach Taraporewala Phones & Addresses

  • 24 Carhart Ave, White Plains, NY 10605 (914) 422-0227 (914) 422-0299
  • 24 Carhart Ave APT 204, White Plains, NY 10605 (914) 422-0299
  • San Antonio, TX
  • Chelmsford, MA
  • 9009 Fm 620, Austin, TX 78726 (512) 257-3797

Resumes

Resumes

Irach Taraporewala Photo 1

Senior Consultant

View page
Location:
New York, NY
Industry:
Pharmaceuticals
Work:
Parexel
Senior Consultant
Irach Taraporewala Photo 2

Irach Taraporewala

View page
Location:
Greater New York City Area
Industry:
Pharmaceuticals
Skills:
Regulatory Affairs
cGMP
Medicinal Chemistry
Online Communications
21 CFR Part 11
Drug Discovery
Drug Development
Pharmaceutical Research
Pharmaceutical Industry
Pharmacotherapy
Pharmacueticals
Analytical Chemistry
Clinical Trials
Ophthalmics
R&D
Drug Delivery
Pharmaceutics
Drug Design
Biochemistry
Regulatory Requirements
Quality Assurance
GLP
GMP
FDA
Clinical Development
Cancer
V&V
Chemistry
Clinical Research
Organic Chemistry
Regulatory Submissions
IND
Biotechnology
Vaccines
Validation
Lifesciences
Languages:
English, Gujarati, Hindi, German, Spanish
Awards:
Government of India National Merit Scholar
J N Tata Endowment Scholar

Publications

Us Patents

Preparation Of A Therapeutic Composition

View page
US Patent:
6921542, Jul 26, 2005
Filed:
Jul 22, 2002
Appl. No.:
10/201210
Inventors:
Bernard Friedland - Sarasota FL, US
Shalom Z. Hirschman - Riverdale NY, US
Irach B. Taraporewala - White Plains NY, US
Assignee:
Advanced Viral Research Corp. - Yonkers NY
International Classification:
A61K038/01
US Classification:
424529, 424535, 424548, 514 2, 514 12, 514 44
Abstract:
Product R, a novel therapeutic composition for treating viral infections and stimulating the immune system, comprises a unique peptide having 31 amino acids and another unique peptide having 21 amino acids and connected with an oligo-nucleotide through a diphosphodiester or diphosphodithioate ester linkage. The composition has a light absorption spectrum with typical absorption ratios of 1. 998 at 260 nm/280 nm and 1. 359 at 260 nm/230 nm.

Preparation Of A Therapeutic Composition

View page
US Patent:
7074767, Jul 11, 2006
Filed:
Jul 22, 2002
Appl. No.:
10/201206
Inventors:
Bernard Friedland - Sarasota FL, US
Shalom Z. Hirschman - Riverdale NY, US
Irach B. Taraporewala - White Plains NY, US
Assignee:
Advanced Viral Research Corp. - Yonkers NY
International Classification:
A61K 38/17
US Classification:
514 21, 424529, 424535, 424548, 514 2, 514 44, 530300, 530324
Abstract:
Product R, a novel therapeutic composition for treating viral infections and stimulating the immune system, comprises a unique peptide having 31 amino acids and another unique peptide having 21 amino acids and connected with an oligo-nucleotide through a diphosphodiester or diphosphodithioate ester linkage. The composition has a light absorption spectrum with typical absorption ratios of 1. 998 at 260 nm/280 nm and 1. 359 at 260 nm/230 nm.

Preparation Of A Therapeutic Composition

View page
US Patent:
8084239, Dec 27, 2011
Filed:
Apr 27, 2009
Appl. No.:
12/430554
Inventors:
Shalom Z. Hirschman - Riverdale NY, US
Irach B. Taraporewala - White Plains NY, US
Assignee:
Ohr Pharmaceuticals, Inc - New York NY
International Classification:
C12P 1/06
US Classification:
435169, 435 41, 435 681, 435 701, 435 711
Abstract:
Product R, a novel therapeutic composition for treating viral infections and stimulating the immune system comprises a unique peptide having 31 amino acids and another unique peptide having 21 amino acids and connected with an oligo-nucleotide through a diphosphodiester or diphosphodithioate ester linkage. The composition has a light absorption spectrum with typical absorption ratios of 1. 998 at 260 mn/280 nm and 1. 359 at 260 nm/230 nm.

Preparation Of A Therapeutic Composition

View page
US Patent:
20020004579, Jan 10, 2002
Filed:
Jan 17, 2001
Appl. No.:
09/764017
Inventors:
Bernard Friedland - Sarasota FL, US
Shalom Hirschman - Riverdale NY, US
Irach Taraporewala - White Plains NY, US
Assignee:
Advanced Viral Research Corp.
International Classification:
A61K038/14
A61K048/00
C07K014/00
US Classification:
530/322000, 530/395000, 514/008000
Abstract:
Product R, a novel therapeutic composition for treating viral infections and stimulating the immune system, comprises a unique peptide having 31 amino acids and another unique peptide having 21 amino acids and connected with an oligo-nucleotide through a diphosphodiester or diphosphodithioate ester linkage. The composition has a light absorption spectrum with typical absorption ratios of 1.998 at 260 nm/280 nm and 1.359 at 260 nm/230 nm.

Preparation Of A Therapeutic Composition

View page
US Patent:
20120271032, Oct 25, 2012
Filed:
Dec 23, 2011
Appl. No.:
13/336485
Inventors:
Shalom Z. Hirschman - Riverdale NY, US
Irach B. Taraporewala - White Plains NY, US
Assignee:
OHR PHARMACEUTICAL INC. - New York NY
International Classification:
C07K 19/00
US Classification:
530322
Abstract:
Product R, a novel therapeutic composition for treating viral infections and stimulating the immune system comprises a unique peptide having 31 amino acids and another unique peptide having 21 amino acids and connected with an oligo-nucleotide through a diphosphodiester or diphosphodithioate ester linkage. The composition has a light absorption spectrum with typical absorption ratios of 1.998 at 260 mn/280 nm and 1.359 at 260 nm/230 nm.

Ophthalmic Formulations Of Squalamine

View page
US Patent:
20130281420, Oct 24, 2013
Filed:
Aug 16, 2011
Appl. No.:
13/817306
Inventors:
Irach B. Taraporewala - White Plains NY, US
Samuel I. Backenroth - New York NY, US
Assignee:
Ohr Pharmaceutical, Inc. - New York NY
International Classification:
A61K 9/00
A61K 31/575
US Classification:
514182
Abstract:
The invention relates to ophthalmic formulations of squalamine or its pharmaceutically acceptable salts for the treatment of conditions of the eye such as, for example, wet age-related macular degeneration (wet AMD), choroidal neovascularization, retinopathy, dry age-related macular degeneration (dry AMD), polypoidal choroidal vasculopathy, neovascularization following ocular surgery, macular edema, retinal venous occlusion, subchoroidal neovascularization, retinal epithelial detachment, pterygum or foveal geographic atrophy of the retinal pigment epithelium.

Preparation Of A Therapeutic Composition

View page
US Patent:
20130338069, Dec 19, 2013
Filed:
May 13, 2013
Appl. No.:
13/892942
Inventors:
Irach B. Taraporewala - White Plains NY, US
Assignee:
Ohr Pharmaceutical Inc. - New York NY
International Classification:
A61K 38/17
US Classification:
514 76, 514 209
Abstract:
A pharmaceutical composition includes a peptide nucleotide composition including Peptide A and Peptide B. Peptide A may be characterized by having SEQ. ID NO: 1. Peptide A may also be characterized by including 31 amino acids lacking any cysteine-cysteine cross links and including six spaced-out proline residues and four glutamine residues. Peptide B may be characterized by having SEQ. ID NO: 2. Peptide B may also be characterized by including 21 amino acids attached at a seine residue in position 18 to a diadenine (3′-5′) diribonecleotide through a diphosphodiester linkage at the 3′-position.
Control profile
Irach B Taraporewala from White Plains, NY, age ~68 Get Report